A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.
Petersen RS, Bordone L, Riedl MA, Tachdjian R, Craig TJ, Lumry WR, Manning ME, Bernstein JA, Raasch J, Zuraw BL, Deng Y, Newman KB, Alexander VJ, Lui C, Schneider E, Cohn DM.
Petersen RS, et al.
Allergy. 2024 Mar;79(3):724-734. doi: 10.1111/all.15948. Epub 2023 Nov 27.
Allergy. 2024.
PMID: 38009241
Clinical Trial.